In a regulatory filing, Bristol-Myers disclosed that its CEO Giovanni Caforio sold 240K shares of common stock on February 6th in a total transaction size of $17.9M.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BMY:
- Pharma Earnings: Q4 Hits and Misses in a Post-COVID-19 World
- Exscientia announces 1st- in-human trial for Bristol-Myers in-licensed EXS4318
- Bristol-Myers sees FY23 adjusted EPS $7.95-$8.25, consensus $8.00
- Bristol-Myers reports Q4 adjusted EPS $1.82, consensus $1.72
- Notable companies reporting before tomorrow’s open